How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alonso E, Santos A, Solis GJ, Riesco P (2001) On the feasibility of urban wastewater tertiary treatment by membranes: a comparative assessment. Desalination 141:39–51
Andersen H, Siegrist H, Halling-Sonrensen B, Ternes TA (2003) Fate of estrogens in a municipal sewage treatment plant. Environ Sci Technol 37:4021–4026
Artola-Garicano E, Borkent I, Hermens JLM, Vaes WHJ (2003) Removal of two polycyclic musks in sewage treatment plants: freely and dissolved total concentrations, Environ. Sci Technol 37:3111–3116
Balk F, Ford RA (1999) Environmental risk assessment for the polycyclic musks AHTN and HHCB in the EU. I. Fate and exposure assessment. Toxicol Lett 111:37–56
Baronti C, Curini R, D’Ascenzo G, Di Corcia A, Gentili A, Samperi R (2000) Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ Sci Technol 34(24):5059–5066
Bester K (2004) Retention characteristics and balance assessment for two polycyclic musk fragrances (HHCB and AHTN) in a typical German sewage treatment plant. Chemosphere 57(8):863–870
Bound JP, Voulvoulis N (2006) Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res 40:2885–2892
Bourin M, Jolliet P, Ballereau F (1997) An overview of the clinical pharmacokinetics of X-ray contrast media. Clinical Pharmacokinet 32(3):180–193
Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 311:863–870
Braga O, Smythe GA, Schäfer AI, Feitz AJ (2005) Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environ Sci Technol 39:3351–3358
Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142(3):169–183
Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12):2918–2926
Carballa M, Omil F, Lema JM (2005) Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 39:4790–4796
Carballa M, Omil F, Alder AC, Lema JM (2006) Comparison between the conventional anaerobic digestion (CAD) of sewage sludge and its combination with a chemical or thermal pre-treatment concerning the removal of Pharmaceuticals and Personal Care Products (PPCPs). Water Sci Technol 53(8):109–117
Carballa M, Omil F, Lema JM (2007a) Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to Pharmaceutical and Personal Care Products (PPCPs). Environ Sci Technol 41:884–890
Carballa M, Omil F, Ternes T, Lema JM (2007b) Fate of Pharmaceutical and Personal Care Products (PPCPs) during anaerobic digestion of sewage sludge. Water Res 41(10):2139–2150
Carballa M, Manterola G, Larrea L, Ternes TA, Omil F, Lema JM (2007c) Influence of ozone pre-treatment on sludge anaerobic digestion: removal of pharmaceutical and personal care products. Chemosphere 67(7):1444–1452
Carballa M, Fink G, Omil F, Lema JM, Ternes TA (2008) Determination of the solid-water distribution coefficient (Kd) of pharmaceutical and personal care products (PPCPs) in digested sludge. Water Res 42(1–2):287–295
Clara M, Strenn B, Ausserleitner M, Kreuzinger N (2004) Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Water Sci Technol 50(5):29–36
Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005a) The solids retention time—a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39(1):97–106
Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005b) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39(19):4797–4807
Cunningham VL (2004) Special characteristics of pharmaceuticals related to environmental fate. In: Kümmerer K (ed) Pharmaceuticals in the environment: sources, fate, effects and risks. Springer, Germany, pp 12–24
Daughton CG, Ternes TA (1999) Pharmaceuticals and Personal Care Products in the environment: agents of subtle change? Environ Health Perspect 107:907–938
de Mes T, Zeeman G, Lettinga G (2005) Occurence and fate of estrone, E2 and EE2 in STPs for domestic wastewater. Rev Environ Sci Biotechnol 4:275–311
Drewes JE, Heberer T, Reddersen K (2002) Fate of pharmaceuticals during indirect potable reuse. Water Sci Technol 46(3):73–80
Drewes JE, Heberer T, Rauch T, Reddersen K (2003) Fate of pharmaceuticals during ground water recharge. Ground Water Monit Remediat 23:64–72
Fahlenkamp H, Hannich CB, Möhle E, Nöthe T, Ries T (2004) Input and removal of hazardous substances in municipal sewage treatment plants. Chem Ing Tech 76(8):1179–1189
Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76(2):122–159
Flippin JL, Huggett D, Foran CM (2007) Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat Toxicol 81(1):73–78
Gómez MJ, Martínez-Bueno MJ, Lacorte S, Fernández-Alba AR, Agüera A (2007) Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66(6):993–1002
Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131(1–2):5–17
Henry TB, Kwon JW, Armbrust KL, Black MC (2004) Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23(9):2229–2233
Holbrook RD, Novak JT, Grizzard TJ, Love NG (2002) Estrogen receptor agonist fate during wastewater and biosolids treatment processes: a mass balance analysis. Environ Sci Technol 36:4533–4539
Hong HN, Kim HN, Park KS, Lee SK, Gu MB (2007) Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. Chemosphere 67(11):2115–2121
Huber MM, Canonica S, Park GY, von Gunten U (2003) Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ Sci Technol 37(5):1016–1024
Huber MM, Gobel A, Joss A, Hermann N, Loffler D, Mcardell CS, Ried A, Siegrist H, Ternes TA, von Gunten U (2005) Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ Sci Technol 39(11):4290–4299
Jjemba PK (2006) Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 63(1):113–130
Johnson AC, Sumpter JP (2001) Removal of endocrine-disrupting chemicals in activated sludge treatment works. Environ Sci Technol 35(24):4697–4703
Johnson AC, Williams RJ (2004) A model to estimate influent and effluent concentrations of estradiol, estrone and ethinylestradiol at sewage treatment works. Environ Sci Technol 38(13):3649–3658
Johnson AC, Aerni HR, Gerritsen A, Gibert M, Giger W, Hylland K, Jürgens M, Nakari T, Pickering A, Suter JJF, Svenson A, Wettstein FE (2005) Comparing steroid estrogen and nonylphenol content across a range of European sewage plants with different treatment and management practices. Water Res 39:47–58
Jones OAH, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022
Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ Pollut 145:738–744
Joss A, Andersen H, Ternes T, Richle PR, Siegrist H (2004) Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ Sci Technol 38(11):3047–3055
Joss A, Keller E, Alder AC, Gobel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39:3139–3152
Joss A, Zabczynski S, Gobel A, Hoffmann B, Loffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40(8):1686–1696
Kanda R, Griffin P, James HA, Fothergill J (2003) Pharmaceuticals and personal care products in sewage treatment works. J Environ Monit 5:823–830
Khan SJ, Ongerth JE (2002) Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modeling. Water Sci Technol 46(3):105–113
Khan SJ, Ongerth JE (2004) Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. Chemosphere 54:355–367
Kinney CA, Furlong ET, Zaugg SD, Burkhardt MR, Werner SL, Cahill JD, Jorgensen GR (2006) Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci Technol 40(23):7207–7215
Kreuzinger N, Clara M, Stren B, Kroiss H (2004) Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci Technol 50(5):149–156
Kummerer K (2000) Pharmaceuticals in the environment: sources, fate, effects and risks, 2nd edn. Springer, Germany
Kupper T, Berset JD, Etter-Holzer R, Furrer R, Tarradellas J (2004) Concentrations and specific loads of polycyclic musks in sewage sludge originating from a monitoring network in Switzerland. Chemosphere 54:1111–1120
Kupper T, Plagellat C, Braendli RC, de Alencastro LF, Grandjean D, Tarradellas J (2006) Fate and removal of polycyclic musks, UV filters and biocides during wastewater treatment. Water Res 40(14):2603–2612
Matsui S, Takigami H, Matsuda T, Taniguchi N, Adachi J, Kawami H, Shimizu Y (2000) Estrogen and estrogen mimics contamination in water and the role of sewage treatment. Water Sci Technol 42(12):173–179
Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 40(17):3297–3303
Paraskeva P, Graham N (2002) Ozonation of municipal wastewater effluents. Water Environ Res 74:569–581
Pollice A, Lopez A, Laera G, Rubino P, Lonigro A (2004) Tertiary filtered municipal wastewater as alternative water source in agriculture: a field investigation in Southern Italy. Sci Total Environ 324:201–210
Ricking M, Schwarzbauer J, Hellou J, Svenson A, Zitko V (2003) Polycyclic aromatic musk compounds in sewage treatment plant effluents of Canada and Sweden—first results. Mar Pollut Bull 46(4):410–417
Schreurs RHMM, Legler J, Artola-Garicano E, Sinnige TL, Lanser PH, Seinen W, van der Burg B (2004) In vitro and in vivo antiestrogenic effects of polycyclic musks in zebrafish. Environ Sci Technol 38(4):997–1002
Simonich SL, Federle TW, Eckhoff WS, Rottiers A, Webb S, Sabaliunas D, de Wolf W (2002) Removal of fragrance materials during U.S. and European wastewater treatment. Environ Sci Technol 36:2839–2847
Snyder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, Oppenheimer J, Wert EC, Yoon Y (2007) Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202:156–181
Stuer-Lauridsen F, Birkved M, Hansen LP, Lutzhoft HCH, Halling-Sorensen B (2000) Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40(7):783–793
Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225(1–2):135–141
Suarez S, Ramil M, Omil F, Lema JM (2005) Removal of pharmaceutically active compounds in nitrifying–denitrifying plants. Water Sci Technol 52(8):9–14
Suárez S, Dodd MC, Omil F, von Gunten U (2007) Kinetics of triclosan oxidation by aqueous ozone and consequent loss of antibacterial activity: relevance to municipal wastewater ozonation. Water Res 41:2481–2490
Tauche-Wuersch A, de Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39(9):1761–1772
Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32(11):3245–3260
Ternes T, Joss A (2006) Human pharmaceuticals, hormones and fragrances. The challenge of micropollutants in urban water management. IWA Publishing, London
Ternes TA, Kreckel P, Mueller J (1999a) Behaviour and occurrence of estrogens in municipal sewage treatment plants—II. Aerobic batch experiments with activated sludge. Sci Total Environ 225(1–2):91–99
Ternes TA, Stumpf M, Mueller J, Heberer K, Wilken RD, Servos M (1999b) Behavior and occurrence of estrogens in municipal sewage treatment plants—I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225(1–2):81–90
Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch HJ, Gulde BH, Preuss G, Wilme U, Seibert NZ (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36(17):3855–3863
Ternes T, Stüber J, Herrmann N, McDowell D, Ried A, Kampmann M, Teiser B (2003) Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res 37:1976–1982
Ternes TA, Herrmann N, Bonerz M. Knacker T, Siegrist H, Joss A (2004) Determination of Kd-values for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38:4075–4084
Theiβ N (2004) Entwicklung einer analytischen Methode zur Bestimmung von Makrolid- und Sulfonamidantibiotika in Abwasser und Belebtschlamm via LC Tandem Massenspektrometrie, Diplomarbeit für Bingen Fachhochschule, Bingen, Germany
Vader JS, van Ginkel CG, Sperling FMGM, de Jong J, de Boer W, de Graaf JS, van der Most M, Stokman PGW (2000) Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 41(8):1239–1243
Van de Plasche EJ, Balk F (1997) Environmental risk assessment of the polycyclic musks AHTN and HHCB to the EU-TGD, Report No. 601503008, Bilhoven, N.L. National institute of public health and the environment (RIVM)
Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E (2006) Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J Chromatogr A 1115(1–2):187–195